Axa
SPPI

Axa’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Axa’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-26,100
Closed -$33K – 1259
2021
Q4 		$33K Sell
26,100
-371,700
-93% -$665K ﹤0.01% 1151
2021
Q3 		$867K Buy
397,800
+124,000
+45% +$339K ﹤0.01% 991
2021
Q2 		$1.03M Sell
273,800
-6,600
-2% -$22.9K ﹤0.01% 999
2021
Q1 		$914K Hold
280,400
– – ﹤0.01% 986
2020
Q4 		$956K Hold
280,400
– – ﹤0.01% 981
2020
Q3 		$1.14M Hold
280,400
– – ﹤0.01% 913
2020
Q2 		$948K Buy
280,400
+27,900
+11% +$81.3K ﹤0.01% 965
2020
Q1 		$588K Buy
+252,500
New +$691K ﹤0.01% 945

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Axa's SPPI Position: Q1 2022 in Review

Axa sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 26,100 shares — an estimated $33K sold.

Axa first reported a position in SPPI in Q1 2020 and held it in 8 quarters. The position peaked at $1.14M in Q3 2020. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

  • Axa reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Axa sold 26,100 Spectrum Pharmaceuticals Inc shares in Q1 2022, an estimated $33K.
  • Axa first reported a position in Spectrum Pharmaceuticals Inc in Q1 2020 and held it in 8 quarters.
  • Axa's Spectrum Pharmaceuticals Inc position peaked at $1.14M in Q3 2020.
  • 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.